Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henri Bergeron

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
La Revue Du Praticien|May 31, 2022
[Health democracy tested]Henri Bergeron
Journal of Health Politics, Policy and Law|October 18, 2011
Construction of a policy arena: the case of public health in FranceHenri Bergeron, Constance A Nathanson
The Milbank Quarterly|September 13, 2017
Crisis and Change: The Making of a French FDAConstance A Nathanson, Henri Bergeron
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 29, 2026
Expériences et perceptions de la mise à l'échelle d'une intervention de santé publique: entretiens auprès d'une variété d'acteurs françaisNolwenn Stevens, François Alla, Henri Bergeron
Lancet (London, England)|May 6, 2016
Achieving universal health coverage in France: policy reforms and the challenge of inequalitiesOlivier Nay, Sophie Béjean, Daniel Benamouzig, et al.
Plos One|October 22, 2014
Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparisonJean-David Zeitoun, Jérémie H Lefèvre, Nicholas Downing, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional studyJean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
Pharmacoepidemiology and Drug Safety|November 12, 2015
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional studyJean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
La Revue Du Praticien|May 31, 2022
[Health democracy tested]Henri Bergeron
Journal of Health Politics, Policy and Law|October 18, 2011
Construction of a policy arena: the case of public health in FranceHenri Bergeron, Constance A Nathanson
The Milbank Quarterly|September 13, 2017
Crisis and Change: The Making of a French FDAConstance A Nathanson, Henri Bergeron
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|April 29, 2026
Expériences et perceptions de la mise à l'échelle d'une intervention de santé publique: entretiens auprès d'une variété d'acteurs françaisNolwenn Stevens, François Alla, Henri Bergeron
Lancet (London, England)|May 6, 2016
Achieving universal health coverage in France: policy reforms and the challenge of inequalitiesOlivier Nay, Sophie Béjean, Daniel Benamouzig, et al.
Plos One|October 22, 2014
Inconsistencies among European Union pharmaceutical regulator safety communications: a cross-country comparisonJean-David Zeitoun, Jérémie H Lefèvre, Nicholas Downing, et al.
British Journal of Clinical Pharmacology|March 27, 2015
Regulatory review time and post-market safety events for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional studyJean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
Pharmacoepidemiology and Drug Safety|November 12, 2015
Regulatory anticipation of postmarket safety problems for novel medicines approved by the EMA between 2001 and 2010: a cross-sectional studyJean-David Zeitoun, Jérémie H Lefèvre, Nicholas S Downing, et al.
Pageof 1